Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu Min

Showing results (161-170 of 164) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 164 results.
Journal of Gastroenterology and Hepatology|October 13, 2018
Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL studyLai Wei, Ji Dong Jia, Fu Sheng Wang, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 15, 2020
Efficacy and safety of elbasvir/grazoprevir in treatment-naive Chinese adults with hepatitis C virus infection: A randomized trialLai Wei, Ji Dong Jia, Zhong Ping Duan, et al.
ACS Medicinal Chemistry Letters|December 21, 2017
Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease InhibitorsChristopher J Bungard, Peter D Williams, Jurgen Schulz, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding GroupChristopher J Bungard, Peter D Williams, Jeanine E Ballard, et al.
Pageof 17

Showing results (161-170 of 164) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 164 results.
Journal of Gastroenterology and Hepatology|October 13, 2018
Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL studyLai Wei, Ji Dong Jia, Fu Sheng Wang, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 15, 2020
Efficacy and safety of elbasvir/grazoprevir in treatment-naive Chinese adults with hepatitis C virus infection: A randomized trialLai Wei, Ji Dong Jia, Zhong Ping Duan, et al.
ACS Medicinal Chemistry Letters|December 21, 2017
Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease InhibitorsChristopher J Bungard, Peter D Williams, Jurgen Schulz, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding GroupChristopher J Bungard, Peter D Williams, Jeanine E Ballard, et al.
Pageof 17